Study Evaluating the Safety and Efficacy of Tigecycline in Hospitalized Patients With cSSSI
Status:
Completed
Trial end date:
2007-08-01
Target enrollment:
Participant gender:
Summary
Tigecycline's activity against resistant organisms, as well as significant coverage of both
gram-positive and gram-negative bacteria, may provide a valuable therapeutic alternative in
treating patients with complicated skin and/or skin structure infections.